Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins

Published:2017-10 Issue: Volume:473 Page:1-8
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Lucero Diego^ORCID,Miksztowicz Verónica,Gualano Gisela,Longo Cristina,Landeira Graciela,Álvarez Estela,Zago Valeria,Brites Fernando,Berg Gabriela,Fassio Eduardo,Schreier Laura

Funder

Universidad de Buenos Aires

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference46 articles.

1. Harmonizing the Metabolic Syndrome

2. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein;Packard;Biochem. Soc. Trans.,2003

3. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight;Dallinga-Thie;Atherosclerosis,2010

4. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes;Dullaart;Eur. J. Clin. Investig.,2015

5. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome;Adiels;Arterioscler. Thromb. Vasc. Biol.,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease;Nutrition;2024-10

2. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

3. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein;Nature Communications;2024-06-06

4. ApoB100 and Atherosclerosis: What’s New in the 21st Century?;Metabolites;2024-02-12

5. Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD);Metabolites;2023-12-23